Compare Unichem Lab with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DIVIS LABORATORIES UNICHEM LAB/
DIVIS LABORATORIES
 
P/E (TTM) x -100.7 37.2 - View Chart
P/BV x 0.6 6.9 8.0% View Chart
Dividend Yield % 2.5 0.9 283.8%  

Financials

 UNICHEM LAB   DIVIS LABORATORIES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
DIVIS LABORATORIES
Mar-19
UNICHEM LAB/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2921,639 17.8%   
Low Rs1821,115 16.3%   
Sales per share (Unadj.) Rs167.7186.3 90.0%  
Earnings per share (Unadj.) Rs-3.651.0 -7.1%  
Cash flow per share (Unadj.) Rs5.957.3 10.4%  
Dividends per share (Unadj.) Rs4.0016.00 25.0%  
Dividend yield (eoy) %1.71.2 145.3%  
Book value per share (Unadj.) Rs372.3261.8 142.2%  
Shares outstanding (eoy) m70.38265.47 26.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.47.4 19.1%   
Avg P/E ratio x-65.327.0 -241.5%  
P/CF ratio (eoy) x39.924.0 166.0%  
Price / Book Value ratio x0.65.3 12.1%  
Dividend payout %-110.231.4 -350.9%   
Avg Mkt Cap Rs m16,680365,592 4.6%   
No. of employees `0002.611.8 22.0%   
Total wages/salary Rs m2,3935,423 44.1%   
Avg. sales/employee Rs Th4,535.24,175.1 108.6%   
Avg. wages/employee Rs Th919.8457.7 200.9%   
Avg. net profit/employee Rs Th-98.21,141.8 -8.6%   
INCOME DATA
Net Sales Rs m11,80149,463 23.9%  
Other income Rs m9841,556 63.2%   
Total revenues Rs m12,78551,019 25.1%   
Gross profit Rs m-83518,718 -4.5%  
Depreciation Rs m6741,689 39.9%   
Interest Rs m7535 214.9%   
Profit before tax Rs m-60018,551 -3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3435,023 -6.8%   
Profit after tax Rs m-25613,527 -1.9%  
Gross profit margin %-7.137.8 -18.7%  
Effective tax rate %57.327.1 211.5%   
Net profit margin %-2.227.3 -7.9%  
BALANCE SHEET DATA
Current assets Rs m20,38446,501 43.8%   
Current liabilities Rs m5,0298,468 59.4%   
Net working cap to sales %130.176.9 169.2%  
Current ratio x4.15.5 73.8%  
Inventory Days Days105131 80.1%  
Debtors Days Days13586 157.1%  
Net fixed assets Rs m9,02325,797 35.0%   
Share capital Rs m141531 26.5%   
"Free" reserves Rs m26,05868,962 37.8%   
Net worth Rs m26,19969,493 37.7%   
Long term debt Rs m00-   
Total assets Rs m31,49680,383 39.2%  
Interest coverage x-7.0531.0 -1.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.6 60.9%   
Return on assets %-0.616.9 -3.4%  
Return on equity %-1.019.5 -5.0%  
Return on capital %-2.026.7 -7.5%  
Exports to sales %69.40-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m8,18841,238 19.9%   
Fx outflow Rs m59612,405 4.8%   
Net fx Rs m7,59228,833 26.3%   
CASH FLOW
From Operations Rs m-3,2789,543 -34.3%  
From Investments Rs m-2,860-6,854 41.7%  
From Financial Activity Rs m-24-2,459 1.0%  
Net Cashflow Rs m-4,690230 -2,042.8%  

Share Holding

Indian Promoters % 50.1 52.0 96.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 11.8 128.0%  
FIIs % 3.0 19.0 15.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.2 184.3%  
Shareholders   20,176 31,796 63.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 248 Points Lower; Power and IT Stocks Witness Selling(Closing)

Indian share markets fell sharply during closing hours today and ended deep in the red. The BSE Sensex stood lower by 248 points, while the NSE Nifty closed down by 81 points.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

This PSU Turned into a Rare 100 Bagger. Others May Follow.(The 5 Minute Wrapup)

Nov 27, 2019

The lowest hanging fruit for government to raise capital would be to sell off stakes in non-critical PSUs.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 10, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS